Medikit Co Stock

Medikit Co EBITDA per Share

The EBITDA per Share of Medikit Co (7749.T) as of Aug 26, 2026 is 327.34 JPY. In the previous year, EBITDA per Share was 306.51 JPY — a change of 6.80% (higher).

EBITDA per Share

327.34JPY

YoY

6.80%

Last updated:

EBITDA per Share of Medikit Co is 2026 327.34 JPY. EBITDA per Share of Medikit Co was 2025 306.51 JPY. It decreases by 6.80% higher compared to the previous year.

The Medikit Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
222.76 JPY
Jan 1, 2019
241.68 JPY
Jan 1, 2020
268.92 JPY
Jan 1, 2021
236.98 JPY
Jan 1, 2022
277.04 JPY
Jan 1, 2023
261.36 JPY
Jan 1, 2024
306.51 JPY
Jan 1, 2025
327.34 JPY
The Medikit Co EBITDA per Share history
YEAREBITDA per ShareYoY
327.34JPY+6.80%
306.51JPY+17.27%
261.36JPY-5.66%
277.04JPY+16.91%
236.98JPY-11.88%
268.92JPY+11.27%
241.68JPY+8.49%
222.76JPY+3.99%
214.22JPY-2.27%
219.20JPY+12.43%
194.97JPY-46.83%
366.67JPY
Access this data via the Eulerpool API

Medikit Co Stock analysis

What does Medikit Co do? The history of the company Medikit Co Ltd dates back to the 1970s, when the company was founded as a small family business in Japan. Over time, Medikit grew into a multinational company with offices in Asia, Europe, and North America. Medikit's business model is focused on developing, manufacturing, and selling innovative medical devices and consumables. The company specializes in three areas: Medical Instruments, Medical Consumables, and Medical Technology. In the field of Medical Instruments, Medikit offers a wide range of products for use in diagnosis and therapy. These include endoscopes for examining hollow organs such as the stomach and intestines, as well as flexible endoscopes for examining bronchi and lungs. In addition, the range includes ultrasound devices for diagnosing heart, blood vessel, and musculoskeletal disorders, as well as surgical instruments for use in minimally invasive surgery. In the field of Medical Consumables, Medikit offers bandages, injection and infusion sets, catheters and urinary drainage systems, as well as blood collection systems. Products for home care, such as ostomy care and incontinence supplies, are also part of the portfolio. In the field of Medical Technology, Medikit offers technologies for telemedicine and hospital routine. These include systems for wireless transmission of vital parameters such as blood pressure and heart rate, as well as data storage and processing systems for medical examination data. Medikit is constantly striving to improve its products and offer customers the best products. This has resulted in Medikit having one of the best research and development departments in medical technology. Research is conducted, among other things, on better diagnostic procedures and new surgical methods. Another important aspect of Medikit's business model is to work closely with medical facilities and professionals to better understand the needs of customers and offer them customized solutions. This is also reflected in the numerous trainings and workshops that Medikit offers for medical professionals. Overall, Medikit Co Ltd has established itself as a reliable and innovative provider in medical technology. By combining top-notch products with excellent service, the company demonstrates that it stands by its customers in every situation. Medikit Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medikit Co stock

EBITDA per Share of Medikit Co is 327.34 JPY in 2026.

EBITDA per Share of Medikit Co changed from 306.51 JPY to 327.34 JPY, representing a 6.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Medikit Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

Income Statement — Medikit Co

All Key Metrics — Medikit Co